5.26MMarket Cap-1541P/E (TTM)
1.850High1.770Low14.14KVolume1.790Open1.850Pre Close25.46KTurnover0.56%Turnover RatioLossP/E (Static)2.84MShares3.05052wk High0.85P/B4.70MFloat Cap1.21652wk Low--Dividend TTM2.54MShs Float19.500Historical High--Div YieldTTM4.32%Amplitude1.216Historical Low1.800Avg Price1Lot Size
Silo Pharma Stock Forum
Assuming short attack.
News
FYI
The global Alzheimer's disease therapeutics market size is forecasted to exceed $30.8 billion by 2033.
Feel bad for this stock with an important license for Alzheimer’s Disease. I hope you shorters don’t get DAT (Dementia of Alzheimer Type) disease in the future- or your family member. Believe me, you will regret this day.
Update
Benzinga· 2 mins ago
NEWS
Silo Pharma set to Acquire EXCLUSIVE Licensing for Promising Alzheimer’s Disease Therapeutic
Silo Pharma, Inc. announces the licensing of Alzheimer's disease therapeutic SPC-14 from Columbia University, showing cognitive and stress reduction benefits in preclinical models. The Company aims to develop, manufacture, and commercialize SPC-14 globally, expecting to finalize the exclusive license agreement in the first half of 2024.
No comment yet